Back to Trades
Freeman Chris
Chief Commercial OfficerCIK 0001871615
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 11
- Buy transactions
- 0
- Sell transactions
- 12
- Companies
- 1
- Active
- 2025–2026
Freeman Chris, Chief Commercial Officer, has filed 11 SEC reports (2025–2026), all concentrated in Guardant Health, Inc. (GH), totaling $10.9M in disclosed volume. Weighing $0 bought versus $6.1M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
11 loaded
| Jul 2 | GH Guardant Health, Inc. | Freeman Chris | Chief Commercial Officer | Exercise | $536.4K |
| Jun 16 | GH Guardant Health, Inc. | Freeman Chris | Chief Commercial Officer | Exercise | $77.1K |
| May 26 | GH Guardant Health, Inc. | Freeman Chris | Chief Commercial Officer | Sell | $2.9M |
| Apr 2 | GH Guardant Health, Inc. | Freeman Chris | Chief Commercial Officer | Exercise | $433.0K |
| Mar 17 | GH Guardant Health, Inc. | Freeman Chris | Chief Commercial Officer | Exercise | $609.3K |
| Mar 13 | GH Guardant Health, Inc. | Freeman Chris | Chief Commercial Officer | Award | $0 |
| Jan 5 | GH Guardant Health, Inc. | Freeman Chris | Chief Commercial Officer | Exercise | $1.0M |
| Dec 17 | GH Guardant Health, Inc. | Freeman Chris | Chief Commercial Officer | Exercise | $61.0K |
| Dec 8 | GH Guardant Health, Inc. | Freeman Chris | Chief Commercial Officer | Sell | $3.2M |
| Oct 2 | GH Guardant Health, Inc. | Freeman Chris | Chief Commercial Officer | Exercise | $359.6K |
| Sep 17 | GH Guardant Health, Inc. | Freeman Chris | Chief Commercial Officer | Exercise | $32.5K |
11 filings